- English (USA)
- English (UK)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Biocartis Group NV (BCART)Biocartis Group NV stock price live, this page displays EBR BCART stock exchange data. View the BCART premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Biocartis Group NV real time stock price chart below.
What Is the Biocartis Group NV Stock Price Today?
The Biocartis Group NV stock price today is 0.29.
What Is the Stock Symbol for Biocartis Group NV?
The stock symbol for Biocartis Group NV is "BCART."
What Stock Exchange Does Biocartis Group NV Trade On?
Biocartis Group NV is listed and trades on the Brussels stock exchange.
Is Biocartis Group NV a Good Stock to Buy?
Determining whether Biocartis Group NV—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the BCART quote. (ISIN: BE0974281132)
What Is the Biocartis Group NV Stock Price Today?
The Biocartis Group NV stock price today is 0.29.
What Is the Stock Symbol for Biocartis Group NV?
The stock symbol for Biocartis Group NV is "BCART."
What Stock Exchange Does Biocartis Group NV Trade On?
Biocartis Group NV is listed and trades on the Brussels stock exchange.
Is Biocartis Group NV a Good Stock to Buy?
Determining whether Biocartis Group NV—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the BCART quote. (ISIN: BE0974281132)
Brussels
Currency in EUR
0.29
0.00(0.00%)
Closed
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.29
0.29
52 wk Range
0.29
0.29
BCART Scorecard
Full Analysis
Stock generally trades with low price volatility
Trading near 52-week High
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.290.29
52 wk Range
0.290.29
Key Statistics
Edit
Book Value / Share
UnlockFair Value
UnlockFair Value Upside
UnlockEPS Growth Forecast
UnlockN/A
(N/A)
Dividends Payment Streak
UnlockEBITDA
UnlockEV/EBITDA
UnlockBook Value / Share
UnlockFair Value
UnlockFair Value Upside
UnlockEPS Growth Forecast
UnlockN/A
(N/A)
Dividends Payment Streak
UnlockEBITDA
UnlockEV/EBITDA
UnlockBCART Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceFair Price
Upside
Technical Analysis
Strong Sell
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Suffers from weak gross profit margins
Biocartis Group NV Company Profile
Biocartis Group NV, a molecular diagnostics company, provides diagnostic solutions enhancing clinical practice for the benefit of patients, clinicians, payers, and healthcare industry with a focus on oncology. Its proprietary molecular diagnostics Idylla platform is a real-time polymerase chain reaction system that offers molecular information that allows treatment selection and treatment progress monitoring. The company offers Idylla BRAF, KRAS, MSI, EGFR, and NRAS-BRAF mutation tests; and Idylla SARS-CoV-2/Flu/RSV panels and SARS-CoV-2 tests, as well as SeptiCyte RAPID, a rapid host-response test. It also provides research products, including MSI, KRAS, BRAF, ctEGFR, NRAS-BRAF-EGFR S492R, ctKRAS, EGFR, GeneFusion, ctBRAF, and ctNRAS-BRAF-EGFR S492R mutation assays. The company has a collaboration agreement with Amgen to evaluate Idylla RAS testing as a tool for rapid decentralized testing and/or to accelerate access to RAS biomarker information using Idylla platform and RAS tests; and Bristol-Myers Squibb Company for the registration of diagnostic and use of the Idylla MSI test in connection with immuno-oncology therapies. It also has a license, development, and commercialization agreement with GeneproDx for the development of ThyroidPrint novel genomic test on the Idylla platform; and collaboration with APIS Assay Technologies Ltd. to develop and commercialize breast cancer subtyping test on the Idylla platform. The company was founded in 2007 and is headquartered in Mechelen, Belgium.
Compare BCART to Peers and Sector
Metrics to compare | BCART | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipBCARTPeersSector | |
|---|---|---|---|---|
P/E Ratio | 0.0x | −2.4x | −0.6x | |
PEG Ratio | 0.00 | 0.10 | 0.00 | |
Price/Book | 0.0x | 4.2x | 2.6x | |
Price / LTM Sales | 0.0x | 6.9x | 3.2x | |
Upside (Analyst Target) | 0.0% | 90.2% | 44.6% | |
Fair Value Upside | Unlock | 7.0% | 7.3% | Unlock |
FAQ
What Is the Biocartis Group NV (BCART) Stock Price Today?
The Biocartis Group NV stock price today is 0.29.
What Stock Exchange Does Biocartis Group NV Trade On?
Biocartis Group NV is listed and trades on the Brussels stock exchange.
What Is the Stock Symbol for Biocartis Group NV?
The stock symbol for Biocartis Group NV is "BCART."
What Is the Biocartis Group NV Market Cap?
As of today, Biocartis Group NV market cap is 27.24M.
What is Biocartis Group NV Earnings Per Share?
The Biocartis Group NV EPS is -0.866.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.